New research shows certain women are 43 times more likely to develop type 2 diabetes mellitus after childbirth.
Medical and lifestyle interventions successfully lowered the risk of type 2 diabetes in women with a history of gestational diabetes.
Women with polycystic ovary syndrome (PCOS) are at increased risk for metabolic and heart diseases and nearly twice as likely to be hospitalized.
Contrave, a combination of naltrexone and buproprion, has been approved for long-term weight loss management in overweight and obese adults.
Black women born with low birth weight are at increased risk for the later development of type 2 diabetes mellitus, research shows.